Michelson Diagnostics Limited

Kent, United Kingdom



Michelson Diagnostics Ltd., Kent, United Kingdom

Diagnostic imaging company focused on the diagnosis and follow-up treatment-management of non-melanoma skin cancer (“NMSC”).  Utilizing multi-beam optical coherence tomography (“OCT”), VivoSight® OCT enables dermatologists to capture a real-time, continuous scan of a patient’s skin producing high-resolution images of up to 2 millimetres beneath the surface of the skin.


Raise follow-on private financing round to enable Michelson to expand the market adaptation and reimbursement of VivoSight® OCT in Europe and the United States.


Octopus Ventures, Catapult Ventures and angel investors


£1,977,779 Series A2

Our Role

Acted as financial advisor to the Board of Directors and management

  • Prepared marketing materials and compiled electronic data room
  • Designed targeted fund raising campaign approaching a select number of financial and corporate investors.
  • Spearheaded negotiation on behalf of the Company with new and existing investors to complete the transaction.